Thyroid hormones play a critical role in the growth of many organs, especially the brain. Polybrominated diphenyl ethers (PBDEs) and polychlorinated biphenyls (PCBs) interact with the thyroid pathway and may disturb neurodevelopment. This prospective study was designed to examine associations between maternal blood PBDEs and PCBs in early pregnancy and levels of thyroid hormones in maternal and umbilical-cord blood. Levels of low-brominated PBDEs, 3 PCB congeners, total and free thyroid hormones (triiodothyronine (T3) and thyroxine (T4)), thyroid-stimulating hormone, thyroid peroxidase antibodies, iodine, selenium, and mercury were measured in 380 pregnant women in the first trimester who were recruited at the University Hospital Center of Sherbrooke (Quebec, Canada) between September 2007 and December 2008. Thyroid hormone levels were also assessed at delivery and in cord blood (n = 260). Data were analyzed on both a volume basis and a lipid basis. At less than 20 weeks of pregnancy, no relationship was statistically significant in volume-based analysis. In lipid-based models, an inverse association between maternal PBDEs and total T3 and total T4 and a direct association with free T3 and free T4 were observed. At delivery, in both analyses, we observed negative associations between maternal total T4, free T3, cord-blood free T4, and PBDEs and between maternal free T3 and PCBs. Our results suggest that exposure to PBDEs and PCBs in pregnancy may interfere with thyroid hormone levels.
. Despite this regulation, environmental bioaccumulation of PBDEs is very high in Canada (16, 17) . The high levels must be related both to the release of PBDEs from household products, which act as a reservoir for human exposure for years, and to the debromination of deca-PBDE, which is still widely used in the United States and Canada (18) .
PBDEs are characterized by their lipophilicity and bioaccumulation. In the United States, the concentration of PBDEs in pregnant women's plasma is 20-to 106-fold higher than that in comparable Swedish women (19) . The most prevalent PBDE congeners in maternal and umbilical-cord blood are PBDE-47, PBDE-99, PBDE-100, and PBDE-153 (19, 20) . During the past several decades, PBDE levels in the breast milk of North American women were rising exponentially, doubling every 5 years (21) (22) (23) . Among pregnant women, Canadian (24) and US (25) women remain the most exposed in the world.
Pregnant women and their fetuses represent a very sensitive population and are exposed to a mixture of endocrine disruptor pollutants. The relationship of pre-and postnatal PBDE exposure to thyroid hormone levels has been investigated in several epidemiologic studies (Table 1) . PBDE exposure has been found to be associated with changes in maternal and cord-blood thyroid hormone levels (19, (25) (26) (27) (28) (29) (30) (31) (32) (33) . However, studies carried out in early pregnancy, when maternal thyroid hormones are of critical importance, have been lacking.
Thus, the objectives of this study were to investigate the association between maternal blood PBDE concentrations measured in early pregnancy and serum thyroid hormone levels assessed at less than 20 weeks of pregnancy, at delivery, and in cord blood. Because PCBs are suspected of interfering with thyroid hormone levels during pregnancy (34) , our secondary objective was to explore the association of PCBs with thyroid hormones and their interaction with PBDEs.
In addition to conventional methodology, this study included analysis of potentially confounding factors, such as levels of iodine, selenium, and mercury. We also included the measurement of thyroid peroxidase antibodies, which are biomarkers of thyroid autoimmune processes.
MATERIALS AND METHODS

Population recruitment
This study was performed at the Étienne-Lebel Clinical Research Center of the University Hospital Centre of Sherbrooke (Centre hospitalier universitaire de Sherbrooke (CHUS)) in Quebec, Canada. Between September 2007 and December 2008, 397 pregnant women were enrolled at less than 20 weeks of pregnancy, at their first prenatal care visit. Eligibility criteria were: age ≥18 years, gestational age <20 weeks, and no known thyroid disease. Gestational age was confirmed by ultrasonography. At this visit, maternal blood was collected for analysis of PBDEs, PCBs, and thyroid hormones. At delivery, maternal blood and umbilical-cord blood were collected for thyroid hormone analyses. Blood was collected in 10-mL Vacutainer Hemogard tubes with ethylenediaminetetraacetic acid (BectonDickinson, San Jose, California). The plasma was frozen at −20°C in decontaminated Supelco glass storage tubes (Supelco, Inc., Bellefonte, Pennsylvania). In addition, at enrollment and delivery, maternal and umbilical-cord whole blood samples were obtained in 10-mL metal-free blood collection tubes with 0.05 mL of 15% ethylenediaminetetraacetic acid K3 and stored at 4°C for selenium and mercury analysis, and urine samples were collected in a sterile container for iodine analysis. Height and weight were measured by a nurse and used to calculate body mass index (weight (kg)/height (m) 2 ). PBDE levels were analyzed in 387 of the 397 participants due to the loss of 10 samples resulting from analytical problems. After verification of medical files, a post hoc exclusion criterion was added: use of medication known to affect thyroid hormone levels (n = 7). Thus, the final study population included 380 pregnant women.
During pregnancy, 23 women had miscarriages and 5 had voluntary abortions. Some delivery samples were not obtained because of emergencies arising during childbirth (n = 72), deliveries taking place at other hospitals (n = 4), and withdrawal from the study (n = 11). Post hoc exclusion criteria at birth included use of thyroid medication during pregnancy (n = 12) and twin pregnancy (n = 3). Thus, at delivery, the final study population included 260 pregnancies.
The study protocol was approved by the Human Research Ethics Committee of CHUS, and informed consent was given by each participant.
Questionnaires
Sociodemographic information was collected at baseline using an interview-administered questionnaire, including information on age, education, income, alcohol consumption, smoking, drug use, occupational and recreational exposure to chemicals (solvents, pesticides, metals), medical history, familial history of hypothyroidism, use of medication, and number of dental amalgam fillings. All data on maternal health and obstetrical history, medication use, and delivery were obtained from medical records.
Laboratory analysis
Details on the laboratory analyses are presented in the Web Appendix (available at http://aje.oxfordjournals.org/).
PBDE and PCB analyses. Plasma levels of PBDE (PBDE-47, PBDE-99, PBDE-100, and PBDE-153) and PCB (PCB-138, PCB-153, and PCB-180) congeners were analyzed in our laboratory at Sherbrooke University (Quebec, Canada), based on the method described by Covaci and Voorspoels (35) . Quality control was conducted through regular analyses of water blanks added at every 10th sample, solvent blanks, and random duplicate samples. All blanks were subtracted from sample values on a batch basis. Interbatch coefficients of variation were ≤10% and ≤8% for PBDEs and PCBs, respectively.
Selenium and mercury determinations. Determination of selenium and mercury levels was performed by the Toxicology Center of Quebec at the Quebec Institute for Public Health, using inductively coupled plasma mass spectrometry for selenium and cold vapor atomic absorption spectrophotometry for total blood mercury.
Thyroid function tests. Levels of thyroid-stimulating hormone (TSH), free iodothyronines (free triiodothyronine (T3), free thyroxine (T4)), and thyroid peroxidase antibodies were determined at the CHUS clinical laboratory. Lipid determination. Total plasma lipid level was measured using sulfophosphovanillin colorimetric methods (36) . Iodine determination. Urinary iodine level was measured using the Sandell-Kolthoff colorimetric reaction (37) .
Statistical analysis
For PBDE values below the limit of detection, defined as 3 times the noise level, data analysis was performed using zero for undetectable congeners in the summed values. The relationships between PBDEs, PCBs, thyroid hormones, and population characteristics were examined using Spearman correlations, analysis of variance, and the Wilcoxon test.
Bivariate analysis, with a P value set at less than 0.20, was used to test relationships between thyroid hormone levels and continuous potential covariates such as thyroid peroxidase antibodies, urinary iodine, blood selenium, blood mercury, and maternal and gestational ages, as well as dichotomous potential covariates, including mode of delivery (cesarean section: yes/no), smoking status, alcohol consumption, medication use, familial history of hypothyroidism, and occupational and recreational exposures to chemicals.
Data on PBDE, PCB, and maternal and cord-blood TSH levels were log-normally (log n ) transformed. Normality was tested using the Shapiro-Wilk test, and homoscedasticity of the residuals was visually tested for both the log n -transformed data and nontransformed data. We also calculated Cook's distance influence statistic for the residuals to identify influential observations. Residuals for the log n -transformed data were normally distributed and had homogenous variances, in contrast to those of the nontransformed data. Therefore, for the multiple linear regression analyses, we used the log n -transformed data.
To examine the relationships between maternal (at recruitment and delivery) and cord-blood thyroid hormone levels and each of the exposure biomarkers, variables associated with each maternal or cord-blood thyroid hormone following bivariate analysis (P < 0.20) were introduced into the final regression models, and PBDE and PCB congeners detected in 100% of the samples were included one by one in the models. Interaction between PCBs and PBDEs was tested in each model. All of the models were fitted both with and without the outliers, and results were similar. Thus, in the final models, at recruitment, 1 outlier was excluded respectively from the models for total T3, free T3, and free T4, while at delivery 1 outlier (a case of congenital hypothyroidism) was excluded from the free T3 models and from the cord-blood TSH model.
Thyroid hormones are involved in lipid metabolism, and the reduction in their circulating levels among hypothyroid subjects is associated with an atherogenic lipid profile (38) . In addition, the question of lipid adjustment in the case of lipophilic contaminants has been discussed elsewhere (39) ; there is no consensus yet on this point. Lipid standardization, or the normalization of plasma concentrations of lipophilic contaminants to plasma lipid, has been observed to be highly prone to bias (39) . Thus, we show our results on PBDEs and PCBs expressed on both a plasma volume basis (ng/mL plasma), with total lipids as a continuous variable, and a plasma lipid basis (ng/g lipids).
All statistical analyses were performed using JMP 5.0.1a (40) . The criterion for significance was set at P < 0.05 for multiple regressions and P < 0.15 for interactions. Table 2 presents the sociodemographic characteristics and pregnancy information for the study group. The women were mostly multiparous (69%) and had a high level of education (>12 years). At recruitment, 67 (18%) were considered obese (body mass index >30). The current smokers reported smoking an average of 7.5 cigarettes/day (standard deviation, 4.6; maximum, 20 cigarettes/day) at enrollment and 6.0 cigarettes/day (standard deviation, 4.3; maximum, 20 cigarettes/day) during pregnancy. At recruitment, 5 women declared that they were occasional smokers. According to their medical records, 95% of the women took vitamin supplements, 14% used antinausea medication, 4% used antiasthma medication, and 2% used antidepressant medication.
RESULTS
Population characteristics
Results for thyroid hormones are shown in Table 3 . Only 1 participant had TSH levels below the normal range, and none had a low T4 level (see Table 3 for normal range). Moreover, 34 women (9%) presented with subclinical hypothyroidism, as defined by a normal free T4 level (11.5-22.7 pmol/L) and a TSH level greater than 2.5 mIU/L. A total of 26 women (7%) had a high level of thyroid peroxidase (>34 IU/mL was used as the cutoff level).
Biomarkers of exposure Table 4 shows the distribution of PCB, PBDE, blood selenium, and urinary iodine levels. PBDE-47 accounted for more than 70% of total PBDEs (ΣPBDE). PBDE-47 and PBDE-99 and PCB congeners were detected in more than 90% of the samples. Among PBDE and PCB congeners, intragroup correlations ranged between 0.20 and 0.60 and between 0.60 and 0.76, respectively. PBDE-47 and PCB-153 were positively correlated (Spearman's ρ = 0.25). Maternal age was positively correlated with PCB-153 and PCB-180 but not with PBDEs. No association was observed between subclinical hypothyroidism and serum PBDE and PCB levels.
Cord-blood selenium was detected in all samples, and levels were higher (P = 0.03) in nonsmokers. No association was observed between selenium and maternal or gestational age at recruitment or at delivery.
Mean urinary iodine levels at recruitment and at delivery were similar. A total of 33.4% and 30% of participants had urinary iodine levels lower than 150 µg/L, the World Health Organization iodine deficiency level for pregnant women (41) , at recruitment and at delivery, respectively. Tables 5-7 show results from regression models of maternal and cord-blood thyroid function tests in relation to maternal PBDE levels expressed on a volume basis (ng/mL plasma) and on a lipid basis (ng/g lipids).
Thyroid hormones and PBDEs
At less than 20 weeks of pregnancy (Table 5) , no association was statistically significant in the volume-based analysis. However, in lipid-based models, total T4 was negatively related to PBDE-47, PBDE-99, and ΣPBDE. Total T3 decreased significantly in relation to PBDE-47, PBDE-99, and ΣPBDE. In addition, a positive relationship was observed between free T4 and PBDE-47, PBDE-99, and ΣPBDE and between free T3 and PBDE-99 and ΣPBDE. Serum TSH was not related to PBDEs. As expected, when thyroid peroxidase antibody level was introduced into the model as a covariate, it was positively associated with TSH in regression models (β = 0.07, P < 0.0001) and negatively associated with free T3 (β = −0.04, P = 0.05). No other relationship was observed in the remaining regression models. Maternal thyroid hormone levels at recruitment were generally unrelated to PCB levels; however, for total T3, an inverse association was seen with PCB-153, PCB-180, and ΣPCBs.
At delivery (Table 6) , volume-based models showed negative associations between maternal total T4 and PBDE-99 and between free T3 and PBDE-47 and ΣPBDE. Maternal free T3 was inversely correlated with PCB-153. Likewise, a decrease of total T3 in relation to PBDE-47 and ΣPBDE and a marginal negative association between free T4 and PBDE-99 were observed. As with the volume-based analysis, the lipid-based results showed that maternal total T4 decreased in relation to PBDE-99. A negative association was observed between free T3 and PBDE-47, and a marginal association with ΣPBDE. No relationships were observed between serum total T3, free T4, TSH, and PBDE congeners. Free T3 was also negatively associated with PCB-138, PCB-153, and ΣPCB, and the association was marginally significant (P < 0.1) for PCB-180. Finally, for thyroid hormones measured in umbilical-cord blood (Table 7) , in volume-based models, free T4 was negatively associated with PBDE-47, PBDE-99, and ΣPBDE. No association was observed for total T4, total T3, and TSH. In the lipid-based analysis, total T4 and free T4 levels decreased in relation to PBDE-47, PBDE-99, and ΣPBDE. No association was observed between cord-blood thyroid hormones and PCB congeners.
For all of the multiple regression models tested with thyroid hormones at different times of sampling, none of the PCB × PBDE interactions were significant.
DISCUSSION
Our results show that environmental exposure to PBDEs may affect maternal and cord-blood thyroid hormone levels. The most robust results-statistically significant for both lipidbased and volume-based analyses-were the decreases in cordblood free T4 and maternal total T4 and free T3 at delivery, in relation to maternal PBDE exposure in early pregnancy. To our knowledge, our study is the first prospective study to observe this association.
We have presented results obtained using both volumebased and lipid-based approaches. For early pregnancy, the observed decrease in maternal serum total T4 and total T3 levels, as well as an increase in free T4 and free T3 levels, in relation to the most prevalent PBDE congeners was statistically significant only in lipid-based models. This decrease in maternal thyroid hormone levels in early pregnancy may have an impact on normal brain development, especially given that adequate maternal T4 concentrations are crucial for fetal neurodevelopment (42) . Furthermore, a decrease in maternal total T4 is associated with fetal neurogenesis abnormalities (43) , impaired neuronal migration (44, 45) , and neuropsychological disorders (42, 46) . In early pregnancy, the lipid-based models showed an apparent increase in maternal free T3 and free T4, the physiologically available fraction, in relation to PBDE exposure. However, the possibility of artifacts in the measurement of free thyroid hormone levels by conventional immunoassay, due to physiological increases in thyroid-binding proteins in early pregnancy, cannot be excluded. To our knowledge, ours is the only study to have found a relationship between thyroid hormones and PBDEs in early pregnancy; however, in a recent transversal study, Chevrier et al. (33) reported a decrease in TSH and no changes in maternal free T4 and total T4 in relation to PBDE levels in a group of pregnant women in late gestation. Interestingly, among nonpregnant subjects, increased free T4 in relation to PBDEs was reported in 36 New York anglers (47) and in a group of 308 fish consumers (48) . For delivery and cord-blood thyroid hormones, statistical associations were virtually unaffected by the type of lipid adjustment. At delivery, cord-blood total T4, free T4, and TSH levels decreased in relation to PBDEs. The decrease in cordblood thyroid hormones observed in our study is of concern, especially in light of new experimental data in rats showing that the developing brain is unable to compensate for low but still marginally normal (i.e., unchanged TSH levels) T4 levels (49) .
To our knowledge, our study is the first to link cord-blood thyroid function test results to PBDE exposure in utero in early gestation. A number of epidemiologic studies (results summarized in Table 1 ) have examined the relationships between PBDEs and thyroid hormones among pregnant women. Some studies assessed PBDEs and thyroid hormones in cord blood (19, 26, 27, 30, 31) , while others assessed the association between maternal PBDEs and TSH measured during pregnancy (25, 32, 33) or at delivery (19) , as well as the relationship between maternal thyroid hormone levels and cord-blood PBDE levels (27, 29, 31) or maternal PBDEs in the 35th week of pregnancy in relation to cord-blood thyroid hormones (28) . In most of these studies, the investigators reported associations between PBDE concentrations and one or more of the thyroid hormones, but results were inconsistent.
The decrease in thyroid hormone levels in relation to gestational PBDE exposure observed in the present study is consistent with experimental studies carried out in pregnant and developing mammals. Kuriyama et al. (50) administered a single dose of PBDE-99 (300 µg/kg) to pregnant rats on gestational day 6 and observed a decrease in total T4 levels for both dams and their offspring. Kodavanti et al. (51) observed a dose-related decrease in total T4 and an increase in TSH among rat dams and their offspring exposed to PBDE mixture DE-71 (Great Lakes Chemical Corporation, El Dorado, Arizona) from gestational day 6 to weaning. With the same mixture, Zhang et al. (52) reported a decrease in T3 levels in mink offspring. Our research group previously used lowdose PBDE-47 in pregnant sheep (0.2 µg/kg, 2 µg/kg, and 20 µg/kg). We observed a decrease in total T4 and total T3 levels in lambs exposed in utero, without any effect in pregnant sheep (53) . We also reported a decrease in total T4 levels in rat offspring from dams exposed to low-dose PBDE-47 (2.0 µg/kg, 20.0 µg/kg, and 200 µg/kg) (54). Although PCBs are structurally similar to PBDEs, their relationships with thyroid hormones were different. In our pregnant women, PCBs were negatively correlated with total T3 in early pregnancy and with free T3 at delivery but were not correlated with thyroxin levels. Cord-blood thyroid hormones were not correlated with PCBs. Our results are consistent with findings reported by Koopman-Esseboom et al. (55), Takser et al. (34) , and Alvarez-Pedrerol et al. (56) . Finally, our results do not support the hypothesis of a synergistic effect or an interaction effect of PCBs and PBDEs on T4 reduction, as suggested by animal studies (11, 12) .
Although Schisterman et al. (39) have recommended that regression modeling be carried out both with and without lipid correction of lipophilic compounds in blood, this recommendation has rarely been followed. Lipid-based models are commonly used, even though this adjustment is a potential source of bias. It has been shown that the distribution of lipophilic pollutants varies between plasma lipoprotein fractions (57) and that a substantial proportion of these compounds are not associated with lipids in serum (58) . PBDE and PCB lipophilicity and the physiological variations in lipid metabolism during pregnancy (59) , especially in relation to thyroid status, may explain the differences observed as a function of lipid adjustment. Our observations raise the important question of adjustment and suggest that more experimental studies addressing thyroid disruption by lipophilic contaminants should consider blood lipid levels to establish the causal pathway between circulating levels of thyroid hormones, lipids, and lipophilic pollutants.
A strength of this study was the consideration of potentially confounding factors such as urinary iodine, thyroid peroxidase, selenium, and PCBs, as well as metals known to affect thyroid hormone levels, such as mercury. We also applied appropriate exclusion criteria and considered both familial hypothyroidism history and the medical data of the participants. However, one potential source of bias was the method of free thyroid hormone analysis. We used a conventional electrochemiluminescent immunoassay; however, the equilibrium dialysis method is known to be more analytically accurate in pregnant women. In addition, hydroxylated PBDE Abbreviations: CI, confidence interval; PBDE(s), polybrominated diphenyl ether(s); ΣPBDE, total PBDEs; PCB(s), polychlorinated biphenyl(s); ΣPCB, total PCBs. * P < 0.10; **P < 0.05. a Slope (β) and 95% confidence interval from multiple linear regression models. Data on PBDEs, PCBs, and thyroid-stimulating hormone were log-transformed.
b Adjusted for gestational age at delivery, maternal age, urinary iodine at delivery, cord-blood mercury levels, and recreational exposure to metals.
c Adjusted for gestational age at delivery, body mass index, baby's gender, and birth weight. d Adjusted for gestational age at delivery, cesarean section (yes/no), maternal total thyroxine level at delivery, and cord-blood mercury level. metabolites were not measured. These metabolites have been reported to be associated with reductions in thyroid hormone levels (25) . Nevertheless, levels of PBDE metabolites are closely correlated with levels of the parent congener.
In conclusion, our results suggest that PBDE exposure during early pregnancy may disturb T4 levels in umbilical-cord blood. In addition, PBDE levels during early pregnancy are negatively correlated with total T4 and free T3 levels in maternal blood at delivery. In a follow-up study, we plan to examine whether the neurobehavioral skills of children are related to maternal PBDE exposure and thyroid disruption.
